Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.
Majidova N, Aghamaliyeva S, Guliyev M, Dinc G, Akyıldız A, Ozcan E, Akdağ Kahvecıoglu F, Çağrı Yıldırım H, Sever N, Guren AK, Kocaaslan E, Erel P, Agyol Y, Celebi A, Arıkan R, Isık S, Bayoglu IV, Demirci NS, Dizdar Ö, Hacıbekiroğlu I, Kostek O, Sarı M. Majidova N, et al. Among authors: hacibekiroglu i. J Chemother. 2024 Nov 26:1-6. doi: 10.1080/1120009X.2024.2430845. Online ahead of print. J Chemother. 2024. PMID: 39588941
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Özyurt N, Alkan A, Gülbağcı B, Seyyar M, Aydın E, Şahbazlar M, Türker M, Kınıkoğlu O, Yerlikaya T, Dinç G, Aytaç A, Kalkan Z, Ebinç S, Gültürk İ, Keskinkılıç M, İşleyen ZS, Çağlayan D, Türkel A, Aydın E, Şakalar T, Sekmek S, Yıldırım N, Koçak S, Okutur K, Özveren A, Dursun B, Kitaplı S, Eren OÖ, Beypınar İ, Hacıbekiroğlu İ, Çabuk D, Karaman E, Acar Ö, Paydaş S, Eryılmaz MK, Demir B, Oruç Z, Yılmaz M, Biricik FS, Salim DK, Tanrıverdi Ö, Doğan M. Özyurt N, et al. Among authors: hacibekiroglu i. Sci Rep. 2024 Oct 9;14(1):23556. doi: 10.1038/s41598-024-75293-5. Sci Rep. 2024. PMID: 39384975 Free PMC article.
Total Neoadjuvant Therapy Versus Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer: A Multi-Institutional Real-World Study.
Şenocak Taşçı E, Mutlu AU, Saylık O, Ölmez ÖF, Bilici A, Sünger E, Sütçüoğlu O, Çakmak Öksüzoğlu ÖB, Özdemir N, Akdoğan O, Bayoğlu İV, Majidova N, Güren AK, Özen Engin E, Hacıbekiroğlu İ, Er Ö, Dane F, Bozkurt M, Turan Canbaz E, Erdamar S, Aytaç E, Özer L, Yıldız İ. Şenocak Taşçı E, et al. Among authors: hacibekiroglu i. Cancers (Basel). 2024 Sep 21;16(18):3213. doi: 10.3390/cancers16183213. Cancers (Basel). 2024. PMID: 39335184 Free PMC article.
A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.
Gürler F, Tay F, Sucuoğlu İşleyen Z, Yerlikaya T, Hendem E, Esen SA, Sütçüoğlu O, Işık D, Niğdelioğlu B, Özen M, Şahin E, Şakalar T, Şengül Samancı N, Alan Ö, Hacıbekiroğlu İ, Algın E, Yılmaz MK, Türk HM, Öksüzoğlu B, Yavuz A, Yüksel O, Bora H, Yazıcı O, Özet A, Özdemir N. Gürler F, et al. Among authors: hacibekiroglu i. Cancer Med. 2024 Jul;13(14):e70002. doi: 10.1002/cam4.70002. Cancer Med. 2024. PMID: 39030808 Free PMC article.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. N Engl J Med. 2024 Aug 15;391(7):585-597. doi: 10.1056/NEJMoa2402614. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828946 Clinical Trial.
Clinicopathologic Analysis and Prognostic Factors for Survival in Patients with Operable Ampullary Carcinoma: A Multi-Institutional Retrospective Experience.
Demirci NS, Cavdar E, Ozdemir NY, Yuksel S, Iriagac Y, Erdem GU, Odabas H, Hacibekiroglu I, Karaagac M, Ucar M, Ozturk B, Bozkaya Y. Demirci NS, et al. Among authors: hacibekiroglu i. Medicina (Kaunas). 2024 May 16;60(5):818. doi: 10.3390/medicina60050818. Medicina (Kaunas). 2024. PMID: 38793001 Free PMC article.
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sarı M, Kahvecioglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arıkan R, Isık S, Balvan O, Geredelı C, Uygun K, Hacibekiroglu I, Kostek O, Bayoglu IV. Majidova N, et al. Among authors: hacibekiroglu i. Oncol Res Treat. 2024;47(7-8):360-367. doi: 10.1159/000537988. Epub 2024 Apr 2. Oncol Res Treat. 2024. PMID: 38565096 Free article.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Kahraman S, Karakaya S, Kaplan MA, Goksu SS, Ozturk A, Isleyen ZS, Hamdard J, Yildirim S, Dogan T, Isik S, Celebi A, Gulbagci BB, Paksoy N, Dogan M, Turk HM, Bilici A, Tatli AM, Akbas S, Turan N, Hacibekiroglu I, Dogu GG, Aydiner A, Sumbul AT, Akyurek S, Yalciner M, Demirkazik A, Gursoy P, Aykan MB, Sahin E, Karadag İ, Kostek O, Er MM, Artaç M, Duzkopru Y, Aydin D, Isik D, Karakas Y, Kilickap S, Erol C, Demir B, Civelek B, Ergun Y, Akinci MB, Dogan I, Karadurmus N, Yumuk PF, Sendur MAN. Kahraman S, et al. Among authors: hacibekiroglu i. Sci Rep. 2024 Mar 9;14(1):5820. doi: 10.1038/s41598-024-56046-w. Sci Rep. 2024. PMID: 38461209 Free PMC article.
The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.
Köstek O, Demirel A, Hacıoğlu MB, Tastekin D, Karabulut S, Gündogdu A, Sever N, Ayhan M, Çelebi A, Majidova N, Yaşar A, Ağyol Y, Erel P, Kocaaslan E, Güren AK, Arıkan R, Isık S, Ercelep O, Goksu SS, Alandag C, Bilgetekin İ, Caner B, Sahin AB, Gulmez A, Akagunduz B, Kose F, Kaplan MA, Dogan E, Sakalar T, Guven DC, Gurbuz M, Ergun Y, Karaagac M, Turker S, Ozkul O, Yıldız B, Sahin S, Demiray AG, Sari M, Erdogan B, Hacıbekiroglu İ, Çakmak Öksüzoğlu ÖB, Kilickap S, Bilici A, Bayoglu İV, Topaloglu S, Cicin İ. Köstek O, et al. Among authors: hacibekiroglu i. J Chemother. 2024 Nov;36(7):613-621. doi: 10.1080/1120009X.2024.2305066. Epub 2024 Jan 23. J Chemother. 2024. PMID: 38263804
Efficacy of Neoadjuvant Chemotherapy in Lobular and Rare Subtypes of Breast Cancer.
Seber ES, Iriagac Y, Cavdar E, Karaboyun K, Avci O, Yolcu A, Gurdal SO, Oznur M, Ekinci F, Aytac A, Gulturk I, Yilmaz M, Sever N, Kapagan T, Ferhatoglu F, Kahvecioglu FA, Hacibekiroglu I. Seber ES, et al. Among authors: hacibekiroglu i. J Coll Physicians Surg Pak. 2024 Jan;34(1):37-41. doi: 10.29271/jcpsp.2024.01.37. J Coll Physicians Surg Pak. 2024. PMID: 38185958
70 results